WHO defines advanced HIV disease (AHD) as CD4 cell count <200cells/mm3 or WHO stage 3 or 4 in adults and adolescents. All children younger than five years of age are considered to have advanced HIV disease. This includes both individuals presenting to care who are antiretroviral therapy (ART) naive and those returning to care after interrupted treatment.
CD4 cell count testing, while no longer needed to initiate treatment, remains an essential tool for identifying people with AHD. All children younger than 5 years are considered to have AHD, given their heightened risk of disease progression and mortality.
People with AHD are at high risk of death, even after starting ART; this risk increases with decreasing CD4 cell count. The most common causes of severe illness and death are tuberculosis, severe bacterial infections and cryptococcal meningitis.
To reduce morbidity and mortality in people presenting with AHD, WHO recommends offering a package of interventions including screening, treatment and prophylaxis for major opportunistic infections, rapid ART initiation (1), and intensified adherence support interventions (2). The AHD package intends to widen access to key medicines and diagnostics to manage the most common causes of illness and death.
WHO has specific guidance for children and adolescents with advanced HIV disease and for the management of TB, cryptococcal meningitis, histoplasmosis, and skin and oral HIV-associated conditions.
(1) Rapid initiation is defined as within 7 days from the day of HIV diagnosis; people with AHD should be given priority for assessment and initiation.
(2) Intensified adherence support interventions include intensive/enhanced adherence counselling, home visits or phone calls, and home-based/palliative care.
Advanced HIV disease (defined in persons living with HIV with a CD4 cell count of <200cells/mm3 or presenting with a WHO Stage 3/4 AIDS-defining illness)...
People with advanced HIV disease are at very high risk of opportunistic infections and deaths. Despite good progress worldwide towards goals of HIV testing,...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to...
These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and...
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America,...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease,...
More publications
All →Advanced HIV disease (defined in persons living with HIV with a CD4 cell count of <200cells/mm3 or presenting with a WHO Stage 3/4 AIDS-defining...
WHO convened a scoping consultation on severe bacterial infections in advanced HIV disease, consulting with academics, program managers and civil society...
The major causes of morbidity and mortality among children living with HIV in low- and middle-income countries are pneumonia (including Pneumocystis pneumonia), tuberculosis...
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest...